Masimo Co. (NASDAQ:MASI) Holdings Trimmed by Cwm LLC

Cwm LLC decreased its holdings in shares of Masimo Co. (NASDAQ:MASI) by 8.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,070 shares of the medical equipment provider’s stock after selling 93 shares during the quarter. Cwm LLC’s holdings in Masimo were worth $143,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Farallon Capital Management LLC lifted its position in shares of Masimo by 13.6% in the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider’s stock worth $218,742,000 after purchasing an additional 177,914 shares in the last quarter. Thrivent Financial for Lutherans lifted its position in Masimo by 42.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider’s stock worth $153,314,000 after buying an additional 360,497 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Masimo by 107.8% during the 2nd quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider’s stock valued at $85,347,000 after buying an additional 351,523 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Masimo by 45.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider’s stock valued at $66,201,000 after acquiring an additional 165,257 shares in the last quarter. Finally, Bamco Inc. NY acquired a new position in shares of Masimo in the first quarter worth $50,781,000. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Trading Down 0.9 %

Masimo stock opened at $140.74 on Friday. The business’s 50-day simple moving average is $127.05 and its 200-day simple moving average is $125.29. The firm has a market capitalization of $7.48 billion, a PE ratio of 95.74 and a beta of 0.99. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09. Masimo Co. has a 52 week low of $75.36 and a 52 week high of $153.93.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.09. The company had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period last year, the business posted $0.62 EPS. Equities research analysts forecast that Masimo Co. will post 3.88 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on MASI shares. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research report on Friday, September 20th. BTIG Research lifted their price objective on shares of Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Finally, Piper Sandler reissued an “overweight” rating on shares of Masimo in a research report on Friday, October 18th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Masimo presently has an average rating of “Moderate Buy” and an average target price of $145.33.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.